SCHEMBL23851608

SCHEMBL23851608

NC(=S)c1cnc(NCCO)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC3 O15379 6/20 0.36
HDAC1 Q13547 6/20 0.36
HDAC2 Q92769 6/20 0.36
HDAC6 Q9UBN7 5/20 0.36
RECQL P46063 1/20 0.35
MCL1 Q07820 1/20 0.35
CDK1 P06493 1/20 0.35
CCNA2 P20248 2/20 0.34
CDK2 P24941 2/20 0.34
CCNA1 P78396 2/20 0.34
AURKA O14965 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
VNN1 O95497 2/20 0.34
P2RX3 P56373 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7899279 0.76 GAA (0.42) GAAMEN1MAPK1KMT2ARECQL
SCHEMBL23094523 0.74 HDAC3 (0.42) GAAMEN1MAPK1KMT2AHDAC3
SCHEMBL19954278 0.74 GAA (0.44) GAAMEN1MAPK1KMT2ARECQL
SCHEMBL27101553 0.72 NPC1 (0.43) GAAMEN1MAPK1KMT2AHDAC3
SCHEMBL13393612 0.72 MAPK1 (0.52) GAAMEN1MAPK1KMT2ARECQL
SCHEMBL34472754 0.71 MAPK1 (0.46) GAAMEN1MAPK1KMT2AHDAC3
SCHEMBL22084738 0.69 GAA (0.40) GAAMEN1MAPK1KMT2ARECQL
SCHEMBL27081560 0.69 GAA (0.40) GAAMEN1MAPK1KMT2AHDAC3
SCHEMBL146981 0.69 ALDH1A1 (0.71) GAAMEN1MAPK1KMT2ARECQL
SCHEMBL24104406 0.68 GAA (0.43) GAAMEN1MAPK1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883577-B1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY UNIV CASE WESTERN RESERVE (US) 2026-04-08 EP disclosed
US-12336982-B2 Compositions and methods of modulating short-chain dehydrogenase activity RODEO THERAPEUTICS CORPORATION (US) 2025-06-24 US disclosed
CN-113507931-B Compositions and methods for modulating short-chain dehydrogenase activity 卡斯西部储备大学 2025-05-27 CN disclosed
US-20250161277-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-05-22 US disclosed
US-20230039604-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY RODEO THERAPEUTICS CORPORATION 2023-02-09 US disclosed
CN-113507931-A Compositions and methods for modulating short-chain dehydrogenase activity 卡斯西部储备大学 2021-10-15 CN disclosed
EP-3883577-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2021-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161277-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS GAA 420/4885MEN1 4461/4885MAPK1 3373/4885
US-12336982-B2 Compositions and methods of modulating short-chain dehydrogenase activity HPGD, GCDH, HPGDS GAA 420/4885MEN1 4461/4885MAPK1 3373/4885
US-20230039604-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS GAA 420/4885MEN1 4461/4885MAPK1 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.